August JVIR Focuses on Interventional Oncology
The August Journal of Vascular and Interventional Radiolog y focuses on the present and future of interventional oncology.
This special issue includes review articles of the future ( personalized oncology in IR, the changing face of image-guided biopsy in support of personalized medicine, barriers to drug delivery in IO); state-of-the art reviews of the present (the role of sorafenib and chemoembolization for treatment of hepatocellular carcinoma); detailed primers on IO that will serve as durable resources for readers; award-winning science (describing interleukin levels after locoregional cancer therapies, a potential signpost for future adjunctive therapies); perspectives from recognized leaders on the state of comparative ablative therapies in kidney and lung cancer; and meta-analyses and results of existing therapies in cholangiocarcinoma.
- "The Changing Face of Percutaneous Image-guided Biopsy: Molecular Profiling and Genomic Analysis in Current Practice"
- "Cryoablation versus Radiofrequency Ablation for Renal Tumor Ablation: Time to Reassess?"
- Image-guided Thermal Ablation of Tumors Increases the Plasma Level of Interleukin-6 and Interleukin-10
- Image-guided Thermal Ablation of Tumor Increases the Plasma Level of Interleukin-6 and Interleukin-10: Is Plasma Level of Interleukin-6 a Surrogate for Immunogenic Cell Death?
- "Contrast-enhanced US-guided Radiofrequency Ablation of Hepatocellular Carcinoma"
- "Treatment of Medically Inoperable Non–small-cell Lung Cancer with Stereotactic Body Radiation Therapy versus Image-guided Tumor Ablation: Can Interventional Radiology Compete?"
- "Positron Emission Tomography/CT after Yttrium-90 Radioembolization: Current and Future Application"
- "Treatment of Hepatocellular Carcinoma Combining Sorafenib and Transarterial Locoregional Therapy: State of the Science"
- "Metaanalysis of Survival, Complications, and Imaging Response following Chemotherapy-based Transarterial Therapy in Patients with Unresectable Intrahepatic Cholangiocarcinoma "
- Editor’s Suggested Readings in Interventional Oncology
The issue also includes CME Test Questions , which are derived from the article "Personalized Oncology in Interventional Radiology."
The Journal of Vascular and Interventional Radiology (JVIR) is the official scientific journal of the Society of Interventional Radiology . For more than two decades, this peer-reviewed journal has been the preferred reference choice of interventional radiologists, radiologists, cardiologists, vascular surgeons, neurosurgeons and other clinicians who need current and reliable information on every aspect of vascular and interventional radiology. Each issue of JVIR covers the most critical and cutting-edge medical, minimally-invasive, radiological, pathological and socioeconomic issues of importance to vascular and interventional radiologists. JVIR brings more than 6,000 readers monthly clinical studies, laboratory investigations, brief scientific reports, continuing education articles and employment opportunities.
About the Society of Interventional Radiology
Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.
Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. Visit www.SIRweb.org . SIR is holding its 39th Annual Scientific Meeting March 22–27 in San Diego. The meeting’s theme “Convergence” illustrates the multidimensional nature of interventional radiology and additionally reflects the diversity of program’s topics and the members of the broader interventional radiology community who converge at the Annual Scientific Meeting to learn, share and network. This year, SIR celebrates 40 years of innovation and advances in interventional radiology. Visit www.SIRweb.org .